KETOCONAZOLE

KETOCONAZOLE was reported 17636 times

These side effects are most commonly reported by patients taking KETOCONAZOLE:

# Side effect Count
0 DRUG INEFFECTIVE 1779
1 OFF LABEL USE 1268
2 PRURITUS 1020
3 FATIGUE 1004
4 NAUSEA 898
5 RASH 874
6 DIARRHOEA 838
7 HEADACHE 768
8 PAIN 753
9 PSORIASIS 663
10 DYSPNOEA 653
11 DIZZINESS 632
12 PRODUCT USE IN UNAPPROVED INDICATION 600
13 ARTHRALGIA 593
14 CHRONIC KIDNEY DISEASE 521
15 ASTHENIA 497
16 CONDITION AGGRAVATED 493
17 VOMITING 483
18 ANXIETY 481
19 ALOPECIA 478
20 FALL 459
21 DEATH 448
22 RENAL FAILURE 430
23 PNEUMONIA 416
24 PRODUCT DOSE OMISSION ISSUE 415
25 DRUG INTERACTION 410
26 WEIGHT DECREASED 403
27 ERYTHEMA 400
28 ACUTE KIDNEY INJURY 391
29 PAIN IN EXTREMITY 372
30 DRY SKIN 371
31 MALAISE 362
32 DEPRESSION 361
33 COUGH 356
34 SKIN EXFOLIATION 353
35 BACK PAIN 337
36 INSOMNIA 324
37 PYREXIA 318
38 URINARY TRACT INFECTION 311
39 CONSTIPATION 305
40 PERIPHERAL SWELLING 302
41 PRODUCT USE ISSUE 266
42 ANAEMIA 257
43 MUSCLE SPASMS 256
44 ABDOMINAL PAIN 252
45 WEIGHT INCREASED 251
46 DECREASED APPETITE 249
47 HYPERTENSION 249
48 GAIT DISTURBANCE 242
49 HYPERSENSITIVITY 240
50 INJECTION SITE PAIN 239
51 CHEST PAIN 235
52 TREMOR 229
53 MYALGIA 225
54 SOMNOLENCE 218
55 ABDOMINAL PAIN UPPER 216
56 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 215
57 FEELING ABNORMAL 213
58 COVID-19 212
59 EMOTIONAL DISTRESS 210
60 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 210
61 HYPOTENSION 205
62 NASOPHARYNGITIS 202
63 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 200
64 DERMATITIS ATOPIC 198
65 DRUG HYPERSENSITIVITY 190
66 MUSCULAR WEAKNESS 190
67 HYPOAESTHESIA 188
68 URTICARIA 187
69 HAIR TEXTURE ABNORMAL 185
70 DEHYDRATION 184
71 PARAESTHESIA 182
72 INFECTION 178
73 OEDEMA PERIPHERAL 177
74 CONFUSIONAL STATE 175
75 ABDOMINAL DISCOMFORT 171
76 GASTROOESOPHAGEAL REFLUX DISEASE 169
77 ECZEMA 168
78 LOSS OF CONSCIOUSNESS 166
79 BLOOD PRESSURE INCREASED 165
80 SINUSITIS 163
81 ANHEDONIA 162
82 ASTHMA 158
83 NEUROPATHY PERIPHERAL 158
84 TREATMENT FAILURE 158
85 JOINT SWELLING 157
86 SKIN IRRITATION 156
87 DYSPEPSIA 154
88 END STAGE RENAL DISEASE 153
89 VISION BLURRED 150
90 ARTHRITIS 148
91 BLOOD GLUCOSE INCREASED 148
92 ADVERSE DRUG REACTION 147
93 MEMORY IMPAIRMENT 144
94 MIGRAINE 144
95 SEPSIS 141
96 THROMBOCYTOPENIA 141
97 BURNING SENSATION 138
98 GASTROINTESTINAL DISORDER 136
99 CELLULITIS 134
100 ILLNESS 134
101 CONTUSION 133
102 INCORRECT DOSE ADMINISTERED 133
103 PSORIATIC ARTHROPATHY 133
104 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 132
105 SEIZURE 131
106 FUNGAL INFECTION 130
107 HYPOKALAEMIA 130
108 SKIN DISORDER 130
109 VISUAL IMPAIRMENT 130
110 HYPERHIDROSIS 129
111 BRONCHITIS 128
112 SYNCOPE 128
113 DISEASE PROGRESSION 127
114 HOSPITALISATION 127
115 THERAPEUTIC RESPONSE UNEXPECTED 127
116 DYSPHAGIA 126
117 HALLUCINATION 126
118 PALPITATIONS 126
119 BALANCE DISORDER 124
120 OROPHARYNGEAL PAIN 124
121 CARDIAC FAILURE CONGESTIVE 122
122 CEREBROVASCULAR ACCIDENT 122
123 INFLUENZA 122
124 OSTEOARTHRITIS 121
125 ABDOMINAL DISTENSION 120
126 CHEST DISCOMFORT 120
127 SURGERY 120
128 ATRIAL FIBRILLATION 119
129 DRY MOUTH 117
130 HEART RATE INCREASED 117
131 HAEMOGLOBIN DECREASED 115
132 SWELLING 114
133 NEUTROPENIA 112
134 ECONOMIC PROBLEM 110
135 INTENTIONAL PRODUCT MISUSE 110
136 BLOOD CREATININE INCREASED 109
137 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 109
138 RASH PRURITIC 109
139 SUICIDAL IDEATION 109
140 ACNE 108
141 DERMATITIS 107
142 HOT FLUSH 107
143 SKIN BURNING SENSATION 107
144 SLEEP DISORDER 107
145 RHABDOMYOLYSIS 105
146 SWELLING FACE 104
147 RASH ERYTHEMATOUS 103
148 ALANINE AMINOTRANSFERASE INCREASED 101
149 CHILLS 101
150 MYOCARDIAL INFARCTION 101
151 DRY EYE 100
152 TACHYCARDIA 100
153 SEBORRHOEIC DERMATITIS 99
154 DRUG INTOLERANCE 98
155 EYE IRRITATION 98
156 PULMONARY EMBOLISM 98
157 RENAL IMPAIRMENT 98
158 BLISTER 97
159 DIABETES MELLITUS 96
160 NEPHROGENIC ANAEMIA 96
161 SKIN LESION 96
162 EYE PAIN 95
163 ASPARTATE AMINOTRANSFERASE INCREASED 94
164 OEDEMA 94
165 CONTRAINDICATED PRODUCT ADMINISTERED 93
166 DRUG DOSE OMISSION 93
167 MUSCULOSKELETAL STIFFNESS 93
168 PLATELET COUNT DECREASED 93
169 PRODUCT DOSE OMISSION 93
170 SKIN DISCOLOURATION 93
171 ACCIDENTAL EXPOSURE TO PRODUCT 92
172 RHINORRHOEA 92
173 SLEEP APNOEA SYNDROME 92
174 WHITE BLOOD CELL COUNT DECREASED 92
175 HEPATIC ENZYME INCREASED 90
176 INJECTION SITE ERYTHEMA 90
177 STRESS 90
178 UNEVALUABLE EVENT 90
179 OSTEOPOROSIS 89
180 MALIGNANT NEOPLASM PROGRESSION 88
181 SKIN ULCER 88
182 BLOOD CHOLESTEROL INCREASED 87
183 ARTHROPATHY 86
184 DYSPHONIA 86
185 PRODUCT QUALITY ISSUE 86
186 ADRENAL INSUFFICIENCY 84
187 NASAL CONGESTION 84
188 THERAPY INTERRUPTED 84
189 UPPER RESPIRATORY TRACT INFECTION 84
190 FLATULENCE 83
191 THERAPY NON-RESPONDER 83
192 DANDRUFF 82
193 HAIR COLOUR CHANGES 82
194 INTENTIONAL PRODUCT USE ISSUE 82
195 NEPHROLITHIASIS 82
196 THERAPEUTIC RESPONSE DECREASED 82
197 CATARACT 81
198 EPISTAXIS 81
199 HERPES ZOSTER 81
200 INJURY 81
201 OVERDOSE 81
202 PROSTATIC SPECIFIC ANTIGEN INCREASED 81
203 RENAL FAILURE ACUTE 81
204 GASTROINTESTINAL HAEMORRHAGE 80
205 GENERAL PHYSICAL HEALTH DETERIORATION 80
206 OCULAR HYPERAEMIA 80
207 CARDIAC DISORDER 79
208 NO ADVERSE EVENT 79
209 ADVERSE EVENT 78
210 MOBILITY DECREASED 78
211 VERTIGO 78
212 APPLICATION SITE PAIN 77
213 ERECTILE DYSFUNCTION 77
214 PRODUCTIVE COUGH 77
215 THERAPEUTIC RESPONSE SHORTENED 77
216 NECK PAIN 76
217 OXYGEN SATURATION DECREASED 76
218 BONE DENSITY DECREASED 75
219 DEEP VEIN THROMBOSIS 74
220 RENAL INJURY 74
221 AGITATION 73
222 HAEMORRHAGE 73
223 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 73
224 RESPIRATORY FAILURE 73
225 URINARY INCONTINENCE 73
226 WHEEZING 73
227 PLEURAL EFFUSION 72
228 BLOOD PRESSURE DECREASED 71
229 BONE PAIN 71
230 RASH MACULAR 71
231 APPLICATION SITE PRURITUS 70
232 HAEMATOCHEZIA 70
233 THROMBOSIS 70
234 AMNESIA 69
235 PRODUCT ADMINISTRATION INTERRUPTED 69
236 STOMATITIS 69
237 DYSPNOEA EXERTIONAL 68
238 FLUSHING 67
239 HEPATOTOXICITY 66
240 HYPERKALAEMIA 66
241 SINUS DISORDER 66
242 LETHARGY 65
243 FEBRILE NEUTROPENIA 64
244 PAPULE 64
245 POLLAKIURIA 64
246 RHEUMATOID ARTHRITIS 64
247 SCAB 64
248 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 64
249 TINNITUS 64
250 DISCOMFORT 63
251 DYSGEUSIA 63
252 EYE PRURITUS 63
253 INJECTION SITE BRUISING 63
254 INJECTION SITE SWELLING 63
255 PAIN OF SKIN 63
256 SEPTIC SHOCK 63
257 CARDIAC ARREST 62
258 COGNITIVE DISORDER 62
259 GAIT INABILITY 62
260 OSTEOPENIA 62
261 BLOOD ALKALINE PHOSPHATASE INCREASED 61
262 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 61
263 INFLAMMATION 61
264 APPLICATION SITE ERYTHEMA 60
265 DYSURIA 60
266 HYPOGLYCAEMIA 60
267 SKIN FISSURES 60
268 HYPERLIPIDAEMIA 59
269 HYPOTHYROIDISM 59
270 LUNG DISORDER 59
271 SKIN PLAQUE 59
272 TREATMENT NONCOMPLIANCE 59
273 DEPRESSED MOOD 58
274 HYPOXIA 58
275 LEUKOPENIA 58
276 CYSTITIS 57
277 HAEMORRHOIDS 57
278 INFLUENZA LIKE ILLNESS 57
279 LIVER DISORDER 57
280 MUSCULOSKELETAL PAIN 57
281 OSTEONECROSIS 57
282 THERAPEUTIC PRODUCT EFFECT DECREASED 57
283 DRUG EXPOSURE DURING PREGNANCY 56
284 INJECTION SITE PRURITUS 56
285 INTENTIONAL DOSE OMISSION 56
286 CHOLELITHIASIS 55
287 FLUID RETENTION 55
288 HAEMATURIA 55
289 MATERNAL EXPOSURE DURING PREGNANCY 55
290 MENTAL DISORDER 55
291 SPEECH DISORDER 55
292 BLOOD POTASSIUM DECREASED 54
293 ELECTROCARDIOGRAM QT PROLONGED 54
294 HYPONATRAEMIA 54
295 LIVER FUNCTION TEST ABNORMAL 54
296 STAPHYLOCOCCAL INFECTION 54
297 BRADYCARDIA 53
298 HEPATITIS 53
299 RECTAL HAEMORRHAGE 53
300 SKIN LACERATION 53
301 C-REACTIVE PROTEIN INCREASED 52
302 DRUG-INDUCED LIVER INJURY 52
303 DYSKINESIA 52
304 EAR INFECTION 52
305 FEELING HOT 52
306 HYPERCHOLESTEROLAEMIA 52
307 HYPERPARATHYROIDISM SECONDARY 52
308 SKIN HAEMORRHAGE 52
309 BONE DISORDER 51
310 CORONARY ARTERY DISEASE 51
311 NIGHT SWEATS 50
312 THROAT IRRITATION 50
313 URINARY RETENTION 50
314 BLOOD GLUCOSE DECREASED 49
315 HYPERSOMNIA 49
316 PANCYTOPENIA 49
317 SEASONAL ALLERGY 49
318 EYE INFECTION 48
319 INFUSION RELATED REACTION 48
320 LOCALISED INFECTION 48
321 OSTEONECROSIS OF JAW 48
322 RENAL DISORDER 48
323 ANAPHYLACTIC REACTION 47
324 CARDIAC FAILURE 47
325 CROHN^S DISEASE 47
326 EYE DISORDER 47
327 HYPERGLYCAEMIA 47
328 ILL-DEFINED DISORDER 47
329 LIMB INJURY 47
330 PANCREATITIS 47
331 PANIC ATTACK 47
332 SKIN INFECTION 47
333 SWELLING OF EYELID 47
334 ABORTION SPONTANEOUS 46
335 DISTURBANCE IN ATTENTION 46
336 FEEDING DISORDER 46
337 LACRIMATION INCREASED 46
338 MENTAL STATUS CHANGES 46
339 OSTEOMYELITIS 46
340 SPINAL OSTEOARTHRITIS 46
341 TUBULOINTERSTITIAL NEPHRITIS 46
342 ACUTE MYOCARDIAL INFARCTION 45
343 CHROMATURIA 45
344 LIMB DISCOMFORT 45
345 ORTHOSTATIC HYPOTENSION 45
346 TOXICITY TO VARIOUS AGENTS 45
347 TRANSIENT ISCHAEMIC ATTACK 45
348 IMPAIRED GASTRIC EMPTYING 44
349 INTESTINAL OBSTRUCTION 44
350 LYMPHADENOPATHY 44
351 PAIN IN JAW 44
352 ABNORMAL BEHAVIOUR 43
353 CONVULSION 43
354 DERMATITIS CONTACT 43
355 INTERVERTEBRAL DISC PROTRUSION 43
356 IRRITABILITY 43
357 RIB FRACTURE 43
358 WHITE BLOOD CELL COUNT INCREASED 43
359 DEAFNESS 42
360 DYSARTHRIA 42
361 EYE SWELLING 42
362 FOOT DEFORMITY 42
363 HEAD INJURY 42
364 HEPATIC FUNCTION ABNORMAL 42
365 IRRITABLE BOWEL SYNDROME 42
366 METASTASES TO BONE 42
367 NEURALGIA 42
368 WOUND 42
369 BLOOD SODIUM DECREASED 41
370 DEVICE ISSUE 41
371 EXPIRED PRODUCT ADMINISTERED 41
372 FUNGAL SKIN INFECTION 41
373 HEPATIC FAILURE 41
374 IMPAIRED HEALING 41
375 JAUNDICE 41
376 MULTIPLE SCLEROSIS RELAPSE 41
377 PNEUMONIA ASPIRATION 41
378 TRICHORRHEXIS 41
379 BACTERIAL INFECTION 40
380 BLOOD BILIRUBIN INCREASED 40
381 CARDIO-RESPIRATORY ARREST 40
382 CONJUNCTIVITIS 40
383 FOOT FRACTURE 40
384 HAEMATOCRIT DECREASED 40
385 NERVOUSNESS 40
386 PARKINSON^S DISEASE 40
387 PELVIC PAIN 40
388 THERAPY PARTIAL RESPONDER 40
389 TYPE 2 DIABETES MELLITUS 40
390 UNDERDOSE 40
391 VIRAL INFECTION 40
392 VITAMIN D DECREASED 40
393 DYSLIPIDAEMIA 39
394 EOSINOPHILIA 39
395 GASTRITIS 39
396 INTERNATIONAL NORMALISED RATIO INCREASED 39
397 OBESITY 39
398 POOR QUALITY SLEEP 39
399 PRE-EXISTING CONDITION IMPROVED 39
400 PROSTATE CANCER 39
401 SWOLLEN TONGUE 39
402 THERAPY CESSATION 39
403 TOOTH DISORDER 39
404 ARRHYTHMIA 38
405 HYPOACUSIS 38
406 MOUTH ULCERATION 38
407 NEUTROPHIL COUNT DECREASED 38
408 PRODUCT DOSE OMISSION IN ERROR 38
409 SPUTUM DISCOLOURED 38
410 HEART RATE DECREASED 37
411 HYPOPHAGIA 37
412 INJECTION SITE REACTION 37
413 LIP SWELLING 37
414 RASH PAPULAR 37
415 RED BLOOD CELL COUNT DECREASED 37
416 RESTLESSNESS 37
417 SYSTEMIC LUPUS ERYTHEMATOSUS 37
418 TOOTHACHE 37
419 BASAL CELL CARCINOMA 36
420 DRUG EFFECT DECREASED 36
421 NOCTURIA 36
422 ORAL HERPES 36
423 RENAL TUBULAR NECROSIS 36
424 SCAR 36
425 VITAMIN D DEFICIENCY 36
426 AGGRESSION 35
427 EAR PAIN 35
428 GAMMA-GLUTAMYLTRANSFERASE INCREASED 35
429 TOOTH INFECTION 35
430 TRANSAMINASES INCREASED 35
431 ANGIOEDEMA 34
432 ANKLE FRACTURE 34
433 BRAIN FOG 34
434 COLITIS 34
435 DIVERTICULITIS 34
436 DIVERTICULUM 34
437 EXPOSURE DURING PREGNANCY 34
438 FIBROMYALGIA 34
439 GLAUCOMA 34
440 HAEMOPTYSIS 34
441 JOINT STIFFNESS 34
442 ORAL PAIN 34
443 PULMONARY MASS 34
444 PULMONARY OEDEMA 34
445 SEBORRHOEIC KERATOSIS 34
446 SKIN HYPERPIGMENTATION 34
447 SYNOVIAL CYST 34
448 ACUTE RESPIRATORY FAILURE 33
449 ATELECTASIS 33
450 ELECTROLYTE IMBALANCE 33
451 EMOTIONAL DISORDER 33
452 EYELID DISORDER 33
453 HEPATIC CIRRHOSIS 33
454 LIVER FUNCTION TEST INCREASED 33
455 NODULE 33
456 PHOTOSENSITIVITY REACTION 33
457 PRODUCT LABEL ISSUE 33
458 TENDERNESS 33
459 APPLICATION SITE IRRITATION 32
460 DIPLOPIA 32
461 DRUG RESISTANCE 32
462 DYSSTASIA 32
463 HAIR DISORDER 32
464 INTERVERTEBRAL DISC DEGENERATION 32
465 MELANOCYTIC NAEVUS 32
466 MOVEMENT DISORDER 32
467 MUSCULOSKELETAL DISCOMFORT 32
468 NEOPLASM MALIGNANT 32
469 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 32
470 REBOUND ACID HYPERSECRETION 32
471 RENAL CYST 32
472 ROAD TRAFFIC ACCIDENT 32
473 SENSORY DISTURBANCE 32
474 SUSPECTED COUNTERFEIT PRODUCT 32
475 SYNOVITIS 32
476 TOOTH LOSS 32
477 CORTISOL INCREASED 31
478 DYSTONIA 31
479 FEELING COLD 31
480 HAEMATOMA 31
481 INTERSTITIAL LUNG DISEASE 31
482 PRESYNCOPE 31
483 SCRATCH 31
484 THROAT TIGHTNESS 31
485 ARTERIOSCLEROSIS 30
486 BENIGN PROSTATIC HYPERPLASIA 30
487 DENTAL CARIES 30
488 HALLUCINATION, VISUAL 30
489 HEPATIC STEATOSIS 30
490 JAW FRACTURE 30
491 LIBIDO DECREASED 30
492 MOOD ALTERED 30
493 PHOTOPHOBIA 30
494 RESTLESS LEGS SYNDROME 30
495 RHINITIS ALLERGIC 30
496 ROSACEA 30
497 SKIN PAPILLOMA 30
498 TARDIVE DYSKINESIA 30
499 WITHDRAWAL SYNDROME 30
500 ABNORMAL DREAMS 29
501 ACCIDENTAL OVERDOSE 29
502 ACTINIC KERATOSIS 29
503 ANGINA PECTORIS 29
504 APHASIA 29
505 BLOOD POTASSIUM INCREASED 29
506 COAGULOPATHY 29
507 DELIRIUM 29
508 DEMENTIA 29
509 DRUG DEPENDENCE 29
510 EXPOSURE VIA SKIN CONTACT 29
511 FULL BLOOD COUNT ABNORMAL 29
512 HEART RATE IRREGULAR 29
513 HIDRADENITIS 29
514 INTERTRIGO 29
515 MITRAL VALVE INCOMPETENCE 29
516 NASAL ULCER 29
517 NERVE INJURY 29
518 OTITIS MEDIA 29
519 PROTEINURIA 29
520 ROTATOR CUFF SYNDROME 29
521 SCIATICA 29
522 SUICIDE ATTEMPT 29
523 AGEUSIA 28
524 ASCITES 28
525 BLOOD PRESSURE ABNORMAL 28
526 CANDIDA INFECTION 28
527 CARDIAC MURMUR 28
528 CARDIOMEGALY 28
529 CHOLESTASIS 28
530 CLOSTRIDIUM DIFFICILE INFECTION 28
531 CRYING 28
532 DISABILITY 28
533 DISEASE RECURRENCE 28
534 DISORIENTATION 28
535 DRUG EFFECT LESS THAN EXPECTED 28
536 ENDOCRINE OPHTHALMOPATHY 28
537 FOLLICULITIS 28
538 HIATUS HERNIA 28
539 HIP FRACTURE 28
540 JOINT INJURY 28
541 NEPHROPATHY 28
542 NIGHTMARE 28
543 PHARYNGITIS 28
544 RESPIRATORY DISORDER 28
545 RESPIRATORY TRACT INFECTION 28
546 RETCHING 28
547 SEBORRHOEA 28
548 SKIN WEEPING 28
549 BLOOD CREATINE PHOSPHOKINASE INCREASED 27
550 BONE LOSS 27
551 CYST 27
552 HYPERTRIGLYCERIDAEMIA 27
553 INJECTION SITE HAEMORRHAGE 27
554 NAIL DISORDER 27
555 NERVOUS SYSTEM DISORDER 27
556 PLASMA CELL MYELOMA 27
557 PULMONARY HYPERTENSION 27
558 QUALITY OF LIFE DECREASED 27
559 RESPIRATORY DISTRESS 27
560 TASTE DISORDER 27
561 TINEA PEDIS 27
562 ANGER 26
563 COLITIS ULCERATIVE 26
564 DECREASED ACTIVITY 26
565 DRUG LEVEL INCREASED 26
566 EATING DISORDER 26
567 EYE DISCHARGE 26
568 HERPES VIRUS INFECTION 26
569 METABOLIC ACIDOSIS 26
570 MULTIPLE SCLEROSIS 26
571 PRODUCT PHYSICAL ISSUE 26
572 PRODUCT PRESCRIBING ISSUE 26
573 PUSTULE 26
574 RENAL FAILURE CHRONIC 26
575 TRICUSPID VALVE INCOMPETENCE 26
576 UPPER-AIRWAY COUGH SYNDROME 26
577 ABSCESS 25
578 DEVICE MALFUNCTION 25
579 ENCEPHALOPATHY 25
580 EPILEPSY 25
581 FULL BLOOD COUNT DECREASED 25
582 GASTROENTERITIS 25
583 GLYCOSYLATED HAEMOGLOBIN INCREASED 25
584 HYPERKERATOSIS 25
585 MEAN CELL HAEMOGLOBIN INCREASED 25
586 MUSCLE TWITCHING 25
587 PROSTATE CANCER METASTATIC 25
588 PULMONARY FIBROSIS 25
589 RASH GENERALISED 25
590 SINUS CONGESTION 25
591 SKIN SWELLING 25
592 TOXIC SHOCK SYNDROME 25
593 ACUTE RESPIRATORY DISTRESS SYNDROME 24
594 AFFECTIVE DISORDER 24
595 ARTERIOSCLEROSIS CORONARY ARTERY 24
596 BLOOD TESTOSTERONE DECREASED 24
597 CARDIOMYOPATHY 24
598 FAECES DISCOLOURED 24
599 GALLBLADDER DISORDER 24
600 GASTRIC DISORDER 24
601 GASTRIC ULCER 24
602 GOUT 24
603 LIVER INJURY 24
604 MENTAL IMPAIRMENT 24
605 MUCOSAL INFLAMMATION 24
606 MULTIPLE ALLERGIES 24
607 PNEUMOTHORAX 24
608 PRODUCT SUBSTITUTION ISSUE 24
609 SNEEZING 24
610 VAGINAL HAEMORRHAGE 24
611 ACTIVITIES OF DAILY LIVING IMPAIRED 23
612 BLOOD PRESSURE FLUCTUATION 23
613 CARPAL TUNNEL SYNDROME 23
614 CEREBRAL HAEMORRHAGE 23
615 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 23
616 DELUSION 23
617 FREQUENT BOWEL MOVEMENTS 23
618 FURUNCLE 23
619 HALLUCINATION, AUDITORY 23
620 MICTURITION URGENCY 23
621 PALLOR 23
622 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 23
623 PERICARDIAL EFFUSION 23
624 SKIN CANCER 23
625 SKIN MASS 23
626 TOOTH ABSCESS 23
627 VENTRICULAR TACHYCARDIA 23
628 ABDOMINAL PAIN LOWER 22
629 BACK DISORDER 22
630 CHEST X-RAY ABNORMAL 22
631 DECUBITUS ULCER 22
632 DRUG ERUPTION 22
633 FEMUR FRACTURE 22
634 GINGIVITIS 22
635 HOSPICE CARE 22
636 HYPOAESTHESIA ORAL 22
637 IMPETIGO 22
638 INFUSION SITE PAIN 22
639 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 22
640 LABORATORY TEST ABNORMAL 22
641 LUNG INFILTRATION 22
642 LUNG NEOPLASM MALIGNANT 22
643 LYMPHOCYTE COUNT DECREASED 22
644 MASS 22
645 PIGMENTATION DISORDER 22
646 PNEUMONITIS 22
647 RASH MACULO-PAPULAR 22
648 RED BLOOD CELL SEDIMENTATION RATE INCREASED 22
649 THYROID DISORDER 22
650 TOXIC EPIDERMAL NECROLYSIS 22
651 XEROSIS 22
652 BLOOD TRIGLYCERIDES INCREASED 21
653 BREAST CANCER 21
654 CUSHING^S SYNDROME 21
655 EXOSTOSIS 21
656 INCREASED TENDENCY TO BRUISE 21
657 INSURANCE ISSUE 21
658 LOWER RESPIRATORY TRACT INFECTION 21
659 MULTIPLE ORGAN DYSFUNCTION SYNDROME 21
660 ORAL CANDIDIASIS 21
661 PARANOIA 21
662 PHARYNGEAL OEDEMA 21
663 PNEUMOCYSTIS JIROVECII PNEUMONIA 21
664 PRODUCT STORAGE ERROR 21
665 PRODUCT USE COMPLAINT 21
666 SECRETION DISCHARGE 21
667 SINUS TACHYCARDIA 21
668 SLUGGISHNESS 21
669 SMALL INTESTINAL OBSTRUCTION 21
670 STEVENS-JOHNSON SYNDROME 21
671 TOOTH FRACTURE 21
672 VENTRICULAR EXTRASYSTOLES 21
673 BIPOLAR DISORDER 20
674 BLOOD UREA INCREASED 20
675 BODY TEMPERATURE INCREASED 20
676 BURSITIS 20
677 COORDINATION ABNORMAL 20
678 COVID-19 PNEUMONIA 20
679 DERMATITIS ALLERGIC 20
680 DRUG EFFECT INCOMPLETE 20
681 DRUG PRESCRIBING ERROR 20
682 ESSENTIAL HYPERTENSION 20
683 GASTROENTERITIS VIRAL 20
684 GENERALISED OEDEMA 20
685 GENERALISED TONIC-CLONIC SEIZURE 20
686 GYNAECOMASTIA 20
687 INCORRECT PRODUCT ADMINISTRATION DURATION 20
688 LEUKOCYTOSIS 20
689 LIGAMENT SPRAIN 20
690 MIDDLE INSOMNIA 20
691 MUSCLE TIGHTNESS 20
692 ONYCHOMYCOSIS 20
693 PRODUCT PHYSICAL CONSISTENCY ISSUE 20
694 PRODUCT PRESCRIBING ERROR 20
695 SINUS BRADYCARDIA 20
696 VERTIGO POSITIONAL 20
697 ANOREXIA 19
698 AORTIC ARTERIOSCLEROSIS 19
699 BLOOD PRESSURE SYSTOLIC INCREASED 19
700 BODY TINEA 19
701 BRADYKINESIA 19
702 BRONCHOSPASM 19
703 DEPRESSED LEVEL OF CONSCIOUSNESS 19
704 DERMATITIS ACNEIFORM 19
705 DRUG WITHDRAWAL SYNDROME 19
706 EAR DISCOMFORT 19
707 ECCHYMOSIS 19
708 EJECTION FRACTION DECREASED 19
709 FEAR 19
710 HAEMATEMESIS 19
711 HERNIA 19
712 HYDRONEPHROSIS 19
713 HYPOPHOSPHATAEMIA 19
714 ILEUS 19
715 IMMUNODEFICIENCY 19
716 KIDNEY INFECTION 19
717 LEG AMPUTATION 19
718 MAJOR DEPRESSION 19
719 MEDICATION ERROR 19
720 MELAENA 19
721 MULTIPLE FRACTURES 19
722 NEUTROPENIC SEPSIS 19
723 ORAL DISORDER 19
724 PATHOGEN RESISTANCE 19
725 PERIORBITAL SWELLING 19
726 POST PROCEDURAL COMPLICATION 19
727 PRODUCT ODOUR ABNORMAL 19
728 PSEUDOMONAS INFECTION 19
729 PSYCHOTIC DISORDER 19
730 SCOLIOSIS 19
731 SPINAL OPERATION 19
732 SUPRAVENTRICULAR TACHYCARDIA 19
733 THIRST 19
734 ULCER 19
735 VASCULITIS 19
736 VITREOUS FLOATERS 19
737 AGRANULOCYTOSIS 18
738 ARTHROPOD BITE 18
739 ATRIAL FLUTTER 18
740 AUTOIMMUNE DISORDER 18
741 BODY HEIGHT DECREASED 18
742 BONE LESION 18
743 CONTRAINDICATION TO MEDICAL TREATMENT 18
744 DIABETIC NEUROPATHY 18
745 EXTRA DOSE ADMINISTERED 18
746 FOOD ALLERGY 18
747 HAIR GROWTH ABNORMAL 18
748 HAND FRACTURE 18
749 HEAD DISCOMFORT 18
750 INFUSION SITE ERYTHEMA 18
751 IRON DEFICIENCY ANAEMIA 18
752 JAW DISORDER 18
753 JOINT EFFUSION 18
754 KNEE ARTHROPLASTY 18
755 LOOSE TOOTH 18
756 MALNUTRITION 18
757 NEOPLASM 18
758 NEUROTOXICITY 18
759 OBSESSIVE-COMPULSIVE DISORDER 18
760 OESOPHAGITIS 18
761 ORAL DISCOMFORT 18
762 PETECHIAE 18
763 PLATELET COUNT INCREASED 18
764 PRESCRIBED UNDERDOSE 18
765 PRURITUS GENERALISED 18
766 SEXUAL DYSFUNCTION 18
767 SKIN ABRASION 18
768 SKIN REACTION 18
769 SPINAL PAIN 18
770 SPLENOMEGALY 18
771 THINKING ABNORMAL 18
772 THROMBOPHLEBITIS SUPERFICIAL 18
773 UPPER GASTROINTESTINAL HAEMORRHAGE 18
774 APPLICATION SITE RASH 17
775 BLINDNESS 17
776 BLOOD URINE PRESENT 17
777 CHOKING 17
778 COLD SWEAT 17
779 COMPLICATION ASSOCIATED WITH DEVICE 17
780 DIABETES MELLITUS INADEQUATE CONTROL 17
781 DIALYSIS 17
782 DIVERTICULUM INTESTINAL 17
783 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 17
784 EMPHYSEMA 17
785 FAILURE TO THRIVE 17
786 HICCUPS 17
787 HUNGER 17
788 IMPAIRED QUALITY OF LIFE 17
789 IMPAIRED WORK ABILITY 17
790 INITIAL INSOMNIA 17
791 INJECTION SITE MASS 17
792 INJECTION SITE RASH 17
793 INJECTION SITE URTICARIA 17
794 LACTIC ACIDOSIS 17
795 LUMBAR SPINAL STENOSIS 17
796 MACULE 17
797 MALIGNANT MELANOMA 17
798 MULTIPLE INJURIES 17
799 MUSCULOSKELETAL CHEST PAIN 17
800 NEOPLASM PROGRESSION 17
801 NO THERAPEUTIC RESPONSE 17
802 OVARIAN CYST 17
803 PERIPHERAL VASCULAR DISORDER 17
804 PNEUMONIA BACTERIAL 17
805 PRODUCT ADMINISTRATION ERROR 17
806 PRODUCT PACKAGING ISSUE 17
807 SENSITIVE SKIN 17
808 SUBCUTANEOUS ABSCESS 17
809 TENOSYNOVITIS STENOSANS 17
810 WEIGHT FLUCTUATION 17
811 APPLICATION SITE SWELLING 16
812 ARTHRODESIS 16
813 BEDRIDDEN 16
814 BLOOD CHLORIDE DECREASED 16
815 BLOOD GLUCOSE ABNORMAL 16
816 BLOOD IMMUNOGLOBULIN E INCREASED 16
817 BLOOD IRON DECREASED 16
818 BREAST MASS 16
819 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 16
820 CHOLECYSTITIS 16
821 CONCUSSION 16
822 DIZZINESS POSTURAL 16
823 EXTRAPYRAMIDAL DISORDER 16
824 FEELING JITTERY 16
825 FRACTURE 16
826 HAEMORRHAGE INTRACRANIAL 16
827 HEMIPARESIS 16
828 HEPATIC CYTOLYSIS 16
829 HYPERCALCAEMIA 16
830 HYPOCALCAEMIA 16
831 HYPOMAGNESAEMIA 16
832 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 16
833 INJECTION SITE DISCOLOURATION 16
834 LARGE INTESTINE POLYP 16
835 LIP DRY 16
836 LOW DENSITY LIPOPROTEIN INCREASED 16
837 LUNG CONSOLIDATION 16
838 LYMPHOEDEMA 16
839 METASTASES TO LIVER 16
840 MIXED LIVER INJURY 16
841 MUSCULOSKELETAL DISORDER 16
842 ONYCHOCLASIS 16
843 OTITIS MEDIA ACUTE 16
844 PSYCHOMOTOR HYPERACTIVITY 16
845 RESPIRATORY TRACT CONGESTION 16
846 SEDATION 16
847 SKIN HYPERTROPHY 16
848 SPINAL FRACTURE 16
849 TEMPERATURE INTOLERANCE 16
850 THERAPEUTIC PRODUCT INEFFECTIVE 16
851 THERMAL BURN 16
852 UPPER LIMB FRACTURE 16
853 WRIST FRACTURE 16
854 AORTIC ANEURYSM 15
855 ASPERGILLUS TEST POSITIVE 15
856 BACK INJURY 15
857 BLOOD LACTATE DEHYDROGENASE INCREASED 15
858 BLOOD MAGNESIUM DECREASED 15
859 BOWEL MOVEMENT IRREGULARITY 15
860 CHRONIC SINUSITIS 15
861 CLOSTRIDIUM DIFFICILE COLITIS 15
862 COLON CANCER 15
863 DERMATITIS PSORIASIFORM 15
864 DEVICE RELATED INFECTION 15
865 GINGIVAL PAIN 15
866 GLOSSODYNIA 15
867 HEPATOCELLULAR INJURY 15
868 IMMUNE SYSTEM DISORDER 15
869 INJECTION SITE WARMTH 15
870 INTENTIONAL OVERDOSE 15
871 JOINT DISLOCATION 15
872 LIP PAIN 15
873 LYMPHOMA 15
874 MANIA 15
875 MENISCUS INJURY 15
876 METASTASES TO LUNG 15
877 MOOD SWINGS 15
878 MUSCLE FATIGUE 15
879 MYOSITIS 15
880 NERVE COMPRESSION 15
881 OCULAR DISCOMFORT 15
882 PANCREATITIS ACUTE 15
883 PHARYNGEAL SWELLING 15
884 POST-TRAUMATIC STRESS DISORDER 15
885 PRODUCT DISTRIBUTION ISSUE 15
886 PRODUCT RESIDUE PRESENT 15
887 PROSTATOMEGALY 15
888 RASH PUSTULAR 15
889 SALIVARY HYPERSECRETION 15
890 SPINAL DISORDER 15
891 TOOTH EXTRACTION 15
892 UROSEPSIS 15
893 VESTIBULAR DISORDER 15
894 VISUAL ACUITY REDUCED 15
895 ABSCESS LIMB 14
896 APPLICATION SITE DRYNESS 14
897 BREAST PAIN 14
898 BRUXISM 14
899 CARDIOVASCULAR DISORDER 14
900 CENTRAL NERVOUS SYSTEM LESION 14
901 CHOLECYSTECTOMY 14
902 CLOSTRIDIUM TEST POSITIVE 14
903 DIABETIC KETOACIDOSIS 14
904 ELECTROCARDIOGRAM ABNORMAL 14
905 EOSINOPHIL COUNT INCREASED 14
906 FACE OEDEMA 14
907 FISTULA 14
908 FLANK PAIN 14
909 GINGIVAL BLEEDING 14
910 GLUCOSE TOLERANCE IMPAIRED 14
911 HEPATOMEGALY 14
912 HYPOALBUMINAEMIA 14
913 INFUSION SITE EXTRAVASATION 14
914 INFUSION SITE SWELLING 14
915 INJECTION SITE DISCOMFORT 14
916 LACERATION 14
917 LENTIGO 14
918 LUNG INFECTION 14
919 METASTASES TO SPINE 14
920 MUSCLE ATROPHY 14
921 MUSCLE SPASTICITY 14
922 MYCOBACTERIUM AVIUM COMPLEX INFECTION 14
923 NEUTROPHIL COUNT INCREASED 14
924 PRESCRIBED OVERDOSE 14
925 PRODUCT AVAILABILITY ISSUE 14
926 PRODUCT FORMULATION ISSUE 14
927 PROTHROMBIN TIME PROLONGED 14
928 PULMONARY CONGESTION 14
929 PURULENT DISCHARGE 14
930 REBOUND EFFECT 14
931 SPINAL FUSION SURGERY 14
932 SQUAMOUS CELL CARCINOMA 14
933 TENDONITIS 14
934 TINEA VERSICOLOUR 14
935 ABASIA 13
936 ABNORMAL LOSS OF WEIGHT 13
937 ADRENOCORTICAL INSUFFICIENCY ACUTE 13
938 ALTERED STATE OF CONSCIOUSNESS 13
939 ANAL INCONTINENCE 13
940 APHONIA 13
941 APPLICATION SITE VESICLES 13
942 ATRIOVENTRICULAR BLOCK COMPLETE 13
943 BLOOD CREATININE DECREASED 13
944 BRAIN INJURY 13
945 BRONCHIECTASIS 13
946 COMPRESSION FRACTURE 13
947 DEAFNESS BILATERAL 13
948 DERMAL CYST 13
949 FACIAL PAIN 13
950 FEELING DRUNK 13
951 FORMICATION 13
952 HEPATITIS FULMINANT 13
953 HYPOKINESIA 13
954 INCONTINENCE 13
955 INCORRECT DRUG ADMINISTRATION DURATION 13
956 INTENTIONAL SELF-INJURY 13
957 INTERNAL HAEMORRHAGE 13
958 ISCHAEMIC CARDIOMYOPATHY 13
959 LARYNGITIS 13
960 LEFT VENTRICULAR HYPERTROPHY 13
961 LOCAL SWELLING 13
962 LOWER LIMB FRACTURE 13
963 LYMPHOPENIA 13
964 MADAROSIS 13
965 MYDRIASIS 13
966 OBSTRUCTIVE SLEEP APNOEA SYNDROME 13
967 OESOPHAGEAL CANDIDIASIS 13
968 PERFORMANCE STATUS DECREASED 13
969 PNEUMONIA MYCOPLASMAL 13
970 PRODUCT PREPARATION ERROR 13
971 PRURITUS GENITAL 13
972 PSYCHOLOGICAL TRAUMA 13
973 PULMONARY GRANULOMA 13
974 PURPURA SENILE 13
975 RALES 13
976 SENSORY LOSS 13
977 SPINAL COMPRESSION FRACTURE 13
978 SUNBURN 13
979 TARSAL TUNNEL SYNDROME 13
980 TINEA CRURIS 13
981 WRONG TECHNIQUE IN DRUG USAGE PROCESS 13
982 YELLOW SKIN 13
983 ABNORMAL FAECES 12
984 ANAPHYLACTIC SHOCK 12
985 APPETITE DISORDER 12
986 APPLICATION SITE EXFOLIATION 12
987 BACTERIAL TEST POSITIVE 12
988 BLINDNESS UNILATERAL 12
989 BONE DEMINERALISATION 12
990 COELIAC DISEASE 12
991 CRYPTOCOCCOSIS 12
992 DEFORMITY 12
993 DEVICE DISLOCATION 12
994 DEVICE LEAKAGE 12
995 DIASTOLIC DYSFUNCTION 12
996 DRUG ADMINISTERED AT INAPPROPRIATE SITE 12
997 DRUG ADMINISTRATION ERROR 12
998 ERUCTATION 12
999 ERYTHEMA MULTIFORME 12